9574.Se
The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, generating revenue primarily through the sale and distribution of medical products.
Business. The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, generating revenue primarily through the sale and distribution of medical products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, generating revenue primarily through the sale and distribution of medical products.
The company maintains a debt-to-equity ratio of 0.84, indicating a moderate level of leverage, and a current ratio of 1.55, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.
In terms of profitability, the company reports a return on equity (ROE) of 27.77% and a return on assets (ROA) of 9.87%, both of which are strong indicators of efficient capital use and asset management. These figures suggest the company is performing well relative to industry norms, though specific comparisons to cohort medians are not available in the provided data.
The company's revenue is not segmented by geographic region or product line in the available data, so it is not possible to assess revenue concentration or geographic exposure. This lack of segmentation limits the ability to evaluate the company's diversification and potential exposure to regional or market-specific risks.
The company's growth trajectory is not explicitly outlined in the available data, and no numeric deltas for the current or next fiscal year are provided. However, the company's free cash flow of 22,581,800 and operating cash flow of 715,290 indicate a positive cash flow position, which could support future growth initiatives.
The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may need to manage its liquidity carefully to avoid potential financial stress. No specific dilution sources are identified in the available data, and the dilution potential is assessed as low.
No recent events, such as filings or transcripts, are provided in the available data to inform the company's current strategic or operational developments. This absence of recent events limits the ability to assess the company's responsiveness to market changes or internal strategic shifts.
- The company has a strong return on equity (27.77%) and return on assets (9.87%), indicating efficient use of capital and assets.
- The company's debt-to-equity ratio of 0.84 suggests a moderate level of leverage, and its current ratio of 1.55 indicates sufficient short-term liquidity.
- The company's free cash flow of 22,581,800 and operating cash flow of 715,290 support its financial flexibility and potential for growth.
- The company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints that may need to be managed carefully.
- The company's risk assessment indicates a medium level of liquidity risk and a low level of dilution risk.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 9574.SE Market data — financials · 2026-05-27